:: - About QuantomiX / Company Profile

Company Profile

QuantomiX develops and commercializes breakthrough solutions based on its proprietary WETSEM^TM Technology. This technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. Eliminating the need for time-consuming preparation procedures, the WETSEM^TM Technology ensures that sample integrity is not compromised by artifacts. QuantomiX innovative technology opens new opportunities for application-specific tools to improve drug discovery, and advances treatment and diagnostic solutions for the medical and pharmaceutical markets.

Established in 2001, QuantomiX operates in North America, Europe and Asia. The company's managerial team and development staff include an experienced cadre of business and industry professionals.

QuantomiX is a privately held venture-backed company whose major investors include Pitango Venture Capital, Evergreen, VitaLife, and SFKT.


		Company Profile QuantomiX develops and commercializes breakthrough solutions based on its proprietary WETSEM^TM Technology. This technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. Eliminating the need for time-consuming preparation procedures, the WETSEM^TM Technology ensures that sample integrity is not compromised by artifacts. QuantomiX innovative technology opens new opportunities for application-specific tools to improve drug discovery, and advances treatment and diagnostic solutions for the medical and pharmaceutical markets. Established in 2001, QuantomiX operates in North America, Europe and Asia. The company's managerial team and development staff include an experienced cadre of business and industry professionals. QuantomiX is a privately held venture-backed company whose major investors include Pitango Venture Capital, Evergreen, VitaLife, and SFKT.